Anacetrapib as a potential cardioprotective strategy

Por Di Bartolo, Belinda A, Nicholls, Stephen J
Publicado no Drug Des Devel Ther (2017)

Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond

Por Di Bartolo, Belinda A., Scherer, Daniel J., Nicholls, Stephen J.
Publicado no Arch Med Sci (2016)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis

Por Di Bartolo, Belinda A., Schwarz, Nisha, Andrews, Jordan, Nicholls, Stephen J.
Publicado no Arch Med Sci (2016)

TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

Por Di Bartolo, Belinda A., Cartland, Siân P., Harith, Hanis H., Bobryshev, Yuri V., Schoppet, Michael, Kavurma, Mary M.
Publicado em 2013

Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

Por Di Bartolo, Belinda A., Cartland, Siân P., Harith, Hanis H., Bobryshev, Yuri V., Schoppet, Michael, Kavurma, Mary M.
Publicado em 2013

The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit

Por Di Bartolo, Belinda A, Vanags, Laura Z, Tan, Joanne TM, Bao, Shisan, Rye, Kerry-Anne, Barter, Philip J, Bursill, Christina A
Publicado em 2011

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice

Por Cartland, Siân P., Harith, Hanis H., Genner, Scott W., Dang, Lei, Cogger, Victoria C., Vellozzi, Melissa, Di Bartolo, Belinda A., Thomas, Shane R., Adams, Leon A., Kavurma, Mary M.
Publicado no Sci Rep (2017)